Revenue
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.8M | $895,000 | $63,000 | $8,000 | $10.5M | $10.0M | $9.1M | $32,000 | $6,000 | — | — | — | — |
| Gross profit | — | — | — | $6.1M | $6.0M | $5.2M | $4.2M | −$20,000 | — | — | — | — | — |
| Research & development | — | — | — | $5.2M | $12.3M | $7.9M | $4.3M | $980,000 | $375,000 | $257,803 | $241,637 | $156,762 | — |
| Operating expenses | $49.2M | $12.5M | $13.9M | $18.9M | $39.7M | $29.9M | $20.1M | $7.8M | — | $3.1M | $6.8M | — | $25,210 |
| Operating income | −$36.4M | −$11.6M | −$13.8M | −$18.9M | −$33.7M | −$24.7M | −$15.8M | −$7.8M | −$4.7M | −$3.1M | −$6.8M | −$4.9M | −$18,244 |
| EBITDAderived | −$35.1M | −$10.6M | −$11.5M | −$17.8M | −$32.0M | −$23.2M | −$14.8M | −$7.8M | −$4.7M | −$3.1M | −$6.4M | −$4.9M | — |
| Net income | −$148.5M | −$10.3M | −$22.0M | −$37.4M | −$34.5M | −$25.0M | −$15.9M | −$12.1M | −$7.3M | −$4.3M | −$7.0M | −$5.2M | −$18,244 |
| Basic EPSper diluted share | -$5.96 | -$19.36 | -$441.48 | -$6.68 | -$0.55 | -$0.80 | -$0.79 | -$1.23 | -$1.03 | -$0.05 | -$0.11 | -$0.13 | $0.00 |
| Diluted EPSper diluted share | -$5.96 | -$19.36 | -$441.48 | -$6.68 | -$0.55 | -$0.80 | -$0.79 | -$1.23 | -$1.03 | -$0.05 | -$0.11 | -$0.13 | — |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 15, 2026Form 4 | Marbach MaryGeneral Counsel/Corp Secretary | BuyCommon Stock | 1.6K | $3.52 | $5.6K | 1.6K |
| May 14, 2026Form 4/A | Wilson Kevin MarkChief Executive Officer | BuyCommon Stock | 8.0K | $3.66 | $29.4K | 8.0K |
| May 14, 2026Form 4/A | Sohn EvanDirector | BuyCommon Stock | 2.8K | $3.59 | $9.9K | 5.4K |
| May 14, 2026Form 4 | Sohn EvanDirector | BuyCommon Stock | 2.8K | $3.59 | $9.9K | 5.4K |
| May 14, 2026Form 4 | Wilson Kevin MarkChief Executive Officer | BuyCommon Stock | 8.0K | $3.66 | $29.4K | 8.0K |